NCT07334106 Emotional Well-being and Measures of Healthy Aging
| NCT ID | NCT07334106 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2028-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-09-01 with a primary completion date of 2028-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized control study is designed to understand the role of a positive psychology intervention (PARK: Positive Affect Regulation sKills) in biological aging and well-being. PARK provides a series of positive emotion skills in a self-guided online format, making the program accessible and convenient. Our main aims are: Aim 1: To explore the effects of PARK on psychological well-being (e.g., depression, anxiety, positive affect). Aim 2: To explore the effects of PARK on biological age as defined by DNA methylation (DNAm) GrimAge and electrocardiogram-age (ECG-age), as well as physiological well-being in adults (e.g., cardiovascular, endocrine, musculoskeletal functioning, etc.).
Eligibility Criteria
Inclusion Criteria: * Age 40-70 * Speaks and reads English * Able to access the online platform through their phone, a public device (i.e., at the library) or at home. * Lives in the Chicagoland area * Willing/able to travel to the Human Longevity Lab for in-person visits Exclusion Criteria: * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners * Vulnerable Populations * Pre-existing heart disease (prevalent coronary heart and cerebrovascular disease or heart failure) * Type 2 diabetes * Severe psychiatric illness
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07334106 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07334106 currently recruiting?
Yes, NCT07334106 is actively recruiting participants. Contact the research team at chelsea.brown@northwestern.edu for enrollment information.
Where is the NCT07334106 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07334106 clinical trial?
NCT07334106 is sponsored by Northwestern University. The trial plans to enroll 80 participants.